Pharmacovigilance in Mexico is coordinated by COFEPRIS through the Centro Nacional de Farmacovigilancia and the national pharmacovigilance system.
Core official resources
- Pharmacovigilance regulations, guidance and requirements — current COFEPRIS directory for normative and operational PV material.
- Pharmacovigilance in Mexico — overview of the national system and its scope.
- NOM-220-SSA1-2016 status page — confirms the current pharmacovigilance standard and its 2020 modification.
- How to report suspected adverse reactions — reporting routes for different members of the national system.
Practical use
NOM-220-SSA1-2016 remains the core Mexican pharmacovigilance standard, together with its 2020 modification. Operational procedures should be checked against the latest COFEPRIS guidance and reporting instructions because the agency periodically updates implementation material.